Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2021-03-03 Capital/Financing Update
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Agreement to Supply Medicinal Cannabis (Amended) 2 pages 191.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 March 2021 regarding a supply agreement between Murray Meds and an Australian cannabinoid company. It details the terms of the supply agreement, including product types, minimum spend, termination conditions, and comments from the Managing Director. There is no indication that this is a financial report, earnings release, or regulatory filing related to financial results. Instead, it is a corporate announcement about a commercial agreement and business update. This fits best under Capital/Financing Update (CAP) as it relates to business operations and agreements impacting company capital or commercial activities. The document length is about 4913 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2021-03-03 English
Murray Meds signs MOU with Australian based Cannabis Group 2 pages 183.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 2 March 2021 regarding a Memorandum of Understanding (MOU) signed by Murray Meds with an Australian medical cannabis company. It discusses the terms and intentions of the MOU, the acquisition agreement of Murray Meds by ECS Botanics Holdings Ltd, and provides background information about ECS Botanics. The document is relatively short (3656 characters) and is an announcement of a business development and strategic partnership rather than a financial report or detailed regulatory filing. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it contains substantive information about the MOU and acquisition. The content fits best under a general regulatory announcement category for corporate developments that do not fit other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-03-01 English
Results of Meeting 2 pages 188.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 2 March 2021, titled 'RESULTS OF GENERAL MEETING'. It reports the outcome of resolutions put to shareholders at a General Meeting, stating that all resolutions were carried. It references compliance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Act, which relate to disclosure of voting results. The document does not contain financial statements or detailed reports but provides official results of shareholder votes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused solely on voting results, confirming this classification with high confidence.
2021-03-01 English
Change of Address 1 page 143.1KB
Regulatory Filings Classification · 100% confidence The document is an ASX announcement dated 2 March 2021 regarding a change of the company's registered and principal place of business address. It references compliance with Listing Rule 3.14, which pertains to notifying the exchange of changes in company details. The content is a straightforward notice about the change of address and does not contain financial data, management discussion, voting results, or any other report-type information. The document length is short (1688 characters), and it is clearly an announcement rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2021-03-01 English
Half Yearly Report and Accounts 22 pages 501.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D' and is for ECS Botanics Holdings Limited, presenting results for the half-year ended 31 December 2020. It includes detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, and Notes to the Financial Statements. It also contains a Directors' Report, Auditor's Independence Declaration, and an Independent Auditor’s Review Report. The document covers operational review, financial results, capital raising, and events after the reporting date. The presence of comprehensive financial data and analysis for a half-year period clearly identifies this as an Interim / Quarterly Report. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2021
2021-02-22 English
Murray Meds signs European cannabis oil supply 2 pages 189.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 15 February 2021, detailing a three-year supply agreement between Murray Meds and The Armour Group for export and distribution of medicinal cannabis oils. It also mentions ECS Botanics' planned acquisition of Murray Meds, subject to shareholder approval. The content focuses on a business deal and future expectations of sales channels, with no financial statements, quarterly or annual results, or regulatory filings. The document is relatively short (4821 characters) and serves as a corporate announcement about a commercial agreement and acquisition progress. It does not contain financial data or detailed report content. Therefore, it fits best under Capital/Financing Update (CAP), as it relates to a significant business transaction and acquisition update involving capital and supply agreements.
2021-02-14 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.